HONG KONG – An Israeli startup has developed a novel solution for bone treatment that allows for both bone repair and drug delivery to address bone conditions. Bonesci Bio Ltd. is now looking to raise several million dollars in a series A round to further develop Peptoss, a peptide known as FFD5 that mimics certain proteins of bone extracellular matrix.